![William Oh: For men with aggressive prostate cancer, genetic testing can inform treatment decisions.](https://oncodaily.com/pub/uploads/2023/08/William-Oh-1-e1700941036970-1280x951.jpeg)
Photo from William Oh/Linkedin
Oct 3, 2023, 17:22
William Oh: For men with aggressive prostate cancer, genetic testing can inform treatment decisions.
Quoting William Oh, Chief Medical Officer of Prostate Cancer Foundation, on LinkedIn:
”Germline exome sequencing of over 17k men of European ancestry with aggressive and non-aggressive prostate cancer showed an association between the known genes BRCA2, ATM, and NBN with aggressive prostate cancer, in addition to evidence of a link to rare variants in MSH2, XRCC2, and MRE11A. For men with aggressive prostate cancer, genetic testing can inform treatment decisions. We need similar datasets in non-European populations.”
For the article click here.
Source: William Oh/LinkedIn
Jul 19, 2024, 14:12